StockTipsArenaBeta

BUY Gland Pharma Limited — IDBI Capital

BUYGland Pharma Limited
Gland Pharma share price target & all analyst calls

byIDBI CapitalHorizon: NA (inferred Swing (≤2wk))31 Aug 2026via IDBI Capital Research Calls Telegram

Entry₹2,905Stated
Target₹3,070
Total upside +5.68% (call closed)
Stop loss₹2,831-2.55% risk
Exit₹2,8312 Sept 2026, 9:25 am
Stop-loss hit-2.55%
Follow IDBI Capital for new calls(25% target hit, 375 closed calls)Get alertsWatch GLAND for new buy/sell callsGet alertsSee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

Frozen at close · 2 Sept 2026
3 supporting0 opposing
Supports the BUY call (3)

Gland Pharma FY26 Results: Net profit surges 47% to ₹10,273 mn

NewsGoogle News·25 Aug · 1w ago

(opens in new tab)

The biggest upgrades and downgrades by Jefferies during the Q1 results season

NewsCnbc-Tv18·20 Aug · 2w ago

(opens in new tab)

4 advisors have active short-term BUY calls on this stock, with 1 issued in the last 14 days

Advisor consensus · adjacent horizon·19 Aug · 2w ago

Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Gland Pharma

All analyst calls on Gland Pharma

More from IDBI Capital

Every call and its outcome